Saint Jean le Blanc, France

Gérald Guillaumet


Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Saint Jean le Blanc, FR (2001 - 2003)
  • Orleans Cedex 2, FR (2003)

Company Filing History:


Years Active: 2001-2003

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gérald Guillaumet

Introduction

Gérald Guillaumet is a prominent inventor based in Saint Jean le Blanc, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing innovative compounds and compositions aimed at treating various medical conditions, particularly cancers.

Latest Patents

Among his latest patents are several noteworthy inventions. These include polycyclic azaindole compounds and pharmaceutical compositions comprising 4-quinolones for treating cancers. Additionally, he has developed a non-cytotoxic pharmaceutical composition that acts on the proliferation of clonogenic cells in malignant tumors. This composition includes an efficient amount of a compound selected among the compounds of formula (I) and (Ia).

Career Highlights

Gérald Guillaumet has had a distinguished career, working with reputable companies in the pharmaceutical industry. Notably, he has been associated with Les Laboratoires Servier and Adir Et Compagnie. His expertise and innovative approach have contributed to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Gérald has collaborated with several talented individuals, including Marie-Claude Viaud and Caroline Bennejean. These collaborations have fostered a creative environment that has led to the development of groundbreaking pharmaceutical solutions.

Conclusion

Gérald Guillaumet's contributions to the field of pharmaceuticals through his numerous patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical community positively, paving the way for future innovations in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…